[Clinical observation on treatment of 304 patients suffered from acute myocardial infarction with integrated Traditional and Western Medicine].
OBJECTIVE
To make a retrospective survey study on clinical effect and regular pattern of TCM treatment based on Syndrome Differentiation in treating patients of acute myocardial infarction (AMI), admitted in Xiyuan Hospital from January 1978 to December 1997 with integrated traditional Chinese and western medicine.


METHODS
Statistical analysis was made in the following items of 304 patients: age, sex, location of infarction, complication, cause of death, mortality, as well as TCM Syndrome, principle of treatment, prescription and medicinal herbs used.


RESULTS
The incidences of complications in this group for arrhythmia, pump failure, thrombosis were 68.75%, 36.84% and 0.66% respectively, while those in patients treated with western medicine reported by literature in China were 86%-100%, 50% and 2% respectively. Mortality in this group after using thrombolytic therapy was reduced from 17.32% (35/202) to 10.78% (11/102). Types of disease, according to Syndrome Differentiation of TCM, were mainly the Qi-deficiency type, blood stasis type and turbid-phlegm type. And the principle of TCM treatment was mainly to supplement Qi, activate blood circulation and resolve phlegm.


CONCLUSIONS
Integrated traditional Chinese and western medicine treatment of AMI could reducing incidence of complications, such as arrhythmia, pump failure and thrombosis, and thrombolytic therapy could reduce mortality of patients. The frequently encountered TCM Syndrome types and the corresponding therapeutic methods and prescriptions used in treating AMI have also been summarized in this paper.
Dong
Q
Q
Xiyuan Hospital, China Academy of TCM, Beijing (100091).
Wang
X
X
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D012189:Retrospective Studies; D015912:Thrombolytic Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D004365:Drugs, Chinese Herbal; D014568:Urokinase-Type Plasminogen Activator